|
|
|
|
Chronic cyclosporine therapy was associated with a statistically significant but clinically modest delay of progression of disability in a group of patients with multiple sclerosis selected for moderately severe and progressive disease.Close supervision by physicians familiar with cyclosporine is mandatory to minimize known adverse effects,particularly nephrotoxicity,when considering the use of this immunosuppressant. |
|